Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05038475
What this trial is testing

Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionOlfactory Disorder+3 more
Association "Naso Sano" Onlus 100
Not applicableUnknownNCT04459312
What this trial is testing

National Covid-19 Surveillance Physicians

Who this might be right for
Antibody COVID-19
Heinrich-Heine University, Duesseldorf 600
Post-approval studies (Phase 4)Study completedNCT05142319
What this trial is testing

Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]

Who this might be right for
COVID-19
Tan Tock Seng Hospital 326
Not applicableStudy completedNCT04817553
What this trial is testing

Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients

Who this might be right for
IgG4 Related DiseaseCovid19
Chinese University of Hong Kong 124
Large-scale testing (Phase 3)Study completedNCT04546581
What this trial is testing

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

Who this might be right for
COVIDCOVID-19SARS-CoV-2+1 more
University of Minnesota 593
Not applicableStudy completedNCT04751643
What this trial is testing

Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections

Who this might be right for
Intensive Care UnitsARDS, HumanCovid19
Hospices Civils de Lyon 21
Not applicableUnknownNCT04716543
What this trial is testing

Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals

Who this might be right for
Influenza -Like IllnessCovid19
ANRS, Emerging Infectious Diseases 5,400
Not applicableStudy completedNCT04847596
What this trial is testing

Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 25
Not applicableUnknownNCT04779996
What this trial is testing

Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment

Who this might be right for
Covid19CancerHIV Infections
Auxilio Mutuo Cancer Center 250
Not applicableStudy completedNCT04741386
What this trial is testing

The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study

Who this might be right for
Covid19Chronic Kidney Diseases
University Medical Center Groningen 854
Large-scale testing (Phase 3)Ended earlyNCT04910269
What this trial is testing

Outpatient Treatment With Anti-Coronavirus Immunoglobulin

Who this might be right for
COVIDSARS-CoV2 InfectionCovid19
University of Minnesota 741
Not applicableStudy completedNCT04334954
What this trial is testing

SARS-COV2 Pandemic Serosurvey and Blood Sampling

Who this might be right for
SARS-COV2 Virus
National Institute of Allergy and Infectious Diseases (NIAID) 11,363
Not applicableStudy completedNCT06891170
What this trial is testing

B Cell Responses in COVID-19

Who this might be right for
COVID 19
Fondazione IRCCS Policlinico San Matteo di Pavia 4
Not applicableStudy completedNCT04837651
What this trial is testing

Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab

Who this might be right for
Multiple SclerosisDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous System+5 more
Dragonfly Research, LLC 48
Early research (Phase 1)Study completedNCT04519437
What this trial is testing

Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 974
Not applicableUnknownNCT04920357
What this trial is testing

Immune Response to Vaccination Against Covid-19, a Follow up Study

Who this might be right for
Vaccination; InfectionCovid19
Umeå University 3,000
Not applicableStudy completedNCT06989307
What this trial is testing

COVID-19 Serologies Among Healthcare Workers at CHSD (SERO2)

Who this might be right for
COVID-19COVID-19 Serological TestingCOVID-19 Vaccines+3 more
Centre Hospitalier de Saint-Denis 447
Not applicableStudy completedNCT04527432
What this trial is testing

COVID-19 Health Professional Impact Study

Who this might be right for
Coronavirus InfectionSevere Acute Respiratory Syndrome
The Royal Wolverhampton Hospitals NHS Trust 1,504
Not applicableStudy completedNCT04469634
What this trial is testing

Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?

Who this might be right for
SARS-CoV2COVID-19
Institute of Tropical Medicine, Belgium 150
Not applicableLooking for participantsNCT05384509
What this trial is testing

(COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies

Who this might be right for
Cancer
Chang Gung Memorial Hospital 320
Next Page